Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WL8I
|
|||
| Former ID |
DIB012688
|
|||
| Drug Name |
CJ-30001
|
|||
| Synonyms |
HKB-0701 + SLM-0807 (type 2 diabetes), CJ Corp; SLM-0807 + HKB-0701 (type 2 diabetes), CJ Corp
Click to Show/Hide
|
|||
| Indication | Non-insulin dependent diabetes [ICD-11: 5A11] | Phase 3 | [1] | |
| Company |
CJ Corp
|
|||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01370707) A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.